date,title,source
Nov-13-18,ATXI: InvaGen Capital Raise & Acquisition,Zacks Small Cap Research
Nov-13-18,InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.,GlobeNewswire
Nov-14-18,Avenue Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Nov-21-18,"Research Report Identifies Chicken Soup for the Soul Entertainment, Allied Motion Technologies, Bandwidth, Solid Biosciences, Avenue Therapeutics, and BeyondSpring with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Dec-03-18,ATXI: InvaGen Acquisition Spices Up Quarterly Report,Zacks Small Cap Research
Dec-12-18,"SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Avenue Therapeutics, Inc. - ATXI",PR Newswire
Dec-19-18,Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain,GlobeNewswire
Jan-28-19,ATXI: How Much Are CVRs Worth?,Zacks Small Cap Research
